Overnight Health Care: House set to vote on bill targeting drug companies for overcharging Medicaid | Dems press Trump officials on pre-existing conditions | Tobacco giant invests $1.8B in Canadian marijuana grower

Welcome to Friday's Overnight Health Care.

Virginia's Medicaid waiver is now open for public comments, the country's largest tobacco company is getting into the marijuana industry, and President TrumpDonald John TrumpThorny part of obstruction of justice is proving intent, that's a job for Congress Obama condemns attacks in Sri Lanka as 'an attack on humanity' Schiff rips Conway's 'display of alternative facts' on Russian election interference MORE will soon sign a maternal care bill.  

But first some drug pricing news.

 

House set to vote on bill cracking down on drug companies overcharging Medicaid

Congress might be about to take action to crack down on drug companies, a possible sign of things to come next year.

The House is expected to vote next week on a bill to crack down on drug companies that overcharge the government, according to two House aides.

How we got here: The bipartisan bill is aimed at stopping a repeat of the actions from Mylan, the maker of EpiPen, which made headlines last year for overcharging the Medicaid program for its commonly used product by as much as $1.27 billion over 10 years.

ADVERTISEMENT

The bill, from Sens. Chuck GrassleyCharles (Chuck) Ernest GrassleyOn The Money: Inside the Mueller report | Cain undeterred in push for Fed seat | Analysis finds modest boost to economy from new NAFTA | White House says deal will give auto sector B boost The 7 most interesting nuggets from the Mueller report Government report says new NAFTA would have minimal impact on economy MORE (R-Iowa) and Ron WydenRonald (Ron) Lee WydenOn The Money: Inside the Mueller report | Cain undeterred in push for Fed seat | Analysis finds modest boost to economy from new NAFTA | White House says deal will give auto sector B boost Government report says new NAFTA would have minimal impact on economy Hillicon Valley: Washington preps for Mueller report | Barr to hold Thursday presser | Lawmakers dive into AI ethics | FCC chair moves to block China Mobile | Dem bill targets 'digital divide' | Microsoft denies request for facial recognition tech MORE (D-Ore.), allows the government to fine drug companies that misclassify their drugs as generics in order to give smaller discounts to the government.

The House is moving first but there are hopes the Senate will also act soon.

Sign of things to come? The bill is quickly moving forward after being introduced just this week. And Grassley taking over the Finance Committee, combined with Democrats taking over the House, could lead to more action on drug prices, though that is always an uphill battle.

We've got more here.

 

Trump administration considering Medicaid work requirements in Virginia

The Department of Health and Human Services opened the proposal for public comment Friday.

Virginia expanded eligibility for Medicaid earlier this year to more low-income adults, but needs approval from the Trump administration to establish work requirements.

Didn't Virginia just elect a Democratic governor? Yes, but he needed the support of the Republican legislature to expand Medicaid. Republicans agreed to do so if it came with work requirements.

What's next: The comment period ends Jan. 6. The administration will make a decision sometime after that, though it usually takes several months.

Context: The administration has already approved work requirements in Wisconsin, Indiana, Kentucky, Arkansas and New Hampshire.

Arkansas' work requirements are being challenged in court.

Read more here.

 

Altria to invest $1.8 billion in Canadian marijuana grower

Tobacco giant Altria on Friday said it was investing $1.8 billion in Canadian marijuana company Cronos, while also discontinuing its e-cigarette products.

In October, Altria stopped selling e-cigarette "pods" and pulled almost all its flavored products from the market in an attempt to help curb teen vaping. The new move is a sign the company was also struggling to gain traction in a market dominated by Juul.

Altria is the country's largest tobacco company, and manufactures products like Marlboro and Virginia Slim cigarettes.

"We do not see a path to leadership with these particular products and believe that now is the time to refocus our resources. We recognize the impact this decision has on our employees and business partners, which we do not take lightly," Howard Willard, Altria Chairman and CEO, said in a statement.

Growing market: The Food and Drug Administration is also proposing a ban on menthol-flavored cigarettes, which could force Altria to rethink its sales strategy. The large investment in one of Canada's leading cannabis companies could provide that shift. Canada legalized recreational marijuana in October.

Read more here.

 

Top Dems press Trump officials for answers on pre-existing conditions

Four incoming House Democratic chairmen on Friday pressed the Trump administration for answers about its decision to call for overturning ObamaCare's pre-existing condition protections in court.

"In declining to defend these provisions, the Trump Administration is seeking to invalidate these critical patient protections, and once again subject millions of Americans with preexisting conditions to the discrimination they faced before the ACA," the Democrats wrote in a letter to Secretary of Health and Human Services Alex Azar and Centers for Medicare and Medicaid Services Administrator Seema Verma.

Who signed on? The four Democrats, Reps. Frank Pallone Jr.Frank Joseph PalloneAnti-smoking advocates question industry motives for backing higher purchasing age Overnight Health Care: DOJ charges doctors over illegal opioid prescriptions | Cummings accuses GOP of obstructing drug pricing probe | Sanders courts Republican voters with 'Medicare for All' | Dems probe funding of anti-abortion group House Democrats probe Trump administration's funding of anti-abortion group MORE (N.J.), Richard NealRichard Edmund NealOn The Money: House Dem says marijuana banking bill will get vote in spring | Buttigieg joins striking Stop & Shop workers | US home construction slips in March | Uber gets B investment for self-driving cars Democrats should be careful wielding more investigations Dem House chairs: Mueller report 'does not exonerate the president' MORE (Mass.), Bobby ScottRobert (Bobby) Cortez ScottLabor Department official steps down amid ethics questions: report The Congressional Black Caucus: America stands to lose a lot under TrumpCare House passes Paycheck Fairness Act MORE (Va.) and Jerrold Nadler (N.Y.) previously wrote to Azar in June, after the administration declined to defend the Affordable Care Act's pre-existing condition protections in a lawsuit brought by 20 GOP-led states. The Democrats say they never received a substantive response and are now pressing for answers again.

More here

 

Maternity care bill headed to Trump's desk

The Senate on Thursday passed a bipartisan bill that aims to expand access to OB-GYNs in underserved areas.

The bill, sponsored by Energy and Commerce subcommittee on health Chairman Michael BurgessMichael Clifton BurgessOvernight Health Care — Presented by PCMA — Sanders to roll out 'Medicare for all' bill | Dems target Juul over Altria ties | Measles cases spike nationwide GOP rep who supports lowering voting age: 'It's on us' if 16-year-olds vote Democratic Divisions emerge over House drug price bills MORE (R-Texas), passed the House last year.

"This important legislation, now headed to the president's desk to be signed into law, will help to better identify areas in the nation with shortages in maternity care -- ensuring pregnancies are without unnecessary risk and barriers to care regardless of a woman's zip code," said Burgess, a former OB-GYN, in a statement Friday.

Yes, but: Another bill supported by health experts that would address the astounding rate of maternal mortality in the U.S. has not moved from the House or Senate, despite having bipartisan support. It would support state-level efforts to form review committees that specifically track and investigate pregnancy-related deaths and then look for ways to prevent future deaths from occurring.

 

What we're reading

What in the world did this patient cough up? (The Atlantic)

A new way to cut medical errors: talk more to patients and families (STAT)

The real reason ObamaCare enrollment is lagging this year (Vox)

 

State by state

State, federal officials missed warnings at All Children's heart unit in Florida (Tampa Bay Times)

Georgia legislators plan a broad revamp of state's health care regulations (Savannah Now)

New York's ObamaCare sign-ups 'outpacing' 2017 (crainsnewyork.com)